Oberland Capital - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2012
Oberland Capital is a private investment firm focused on providing financing solutions within the healthcare industry. The firm specializes in flexible investment structures tailored to support the development and commercialization of innovative healthcare products. Oberland Capital typically engages in various investment rounds, including Series A, post-IPO debt, and post-IPO equity, with a significant presence in the United States healthcare market.
Notable portfolio companies include ImmunityBio, Mirum Pharmaceuticals, NorthStar Medical Radioisotopes, Primmune Therapeutics, and Zealand Pharma. Oberland Capital's key partners bring extensive experience and industry connections, enhancing their ability to offer unique value-add services such as strategic guidance and operational support to their portfolio companies. This approach aims to create value for partners and transform patient care globally.
Oberland Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages